Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

(PHOTO) Olivia Wilde’s Dramatic Weight Loss Sparks Online Health Concerns and Ozempic Speculation

Published

on

Olivia Wilde is among the famous faces who pop up for socially-distanced conversations during "How It Ends" -- many shot outside the A-listers' real-life homes

LOS ANGELES — Actress and director Olivia Wilde’s noticeably slimmer appearance at the San Francisco International Film Festival in late April 2026 triggered widespread online discussion and health concerns among fans and commentators.

A red-carpet interview video promoting her upcoming film “The Invite” went viral, with many viewers commenting on her angular facial features, sunken cheeks and thinner frame. The footage, originally captured by SFGate, drew millions of views across social media platforms.

Social media users speculated about possible use of weight-loss medications such as Ozempic, rapid dieting or other health-related causes. Some described her look as “skeletal,” “malnourished” or “unwell,” while others attributed the appearance to camera angles, lighting or styling choices.

Wilde, 42, addressed the comments in an Instagram Story posted in early May 2026. In a lighthearted video filmed by her brother, she reacted to a side-by-side comparison with the character Gollum from “The Lord of the Rings.” “Listen, that is a fisheye lens!” Wilde said while laughing. “And I admit, is that my best angle? Was that my best-ever look? No. No. It’s a startling image.” She added, “I’m not dead.”

Advertisement

The actress has not publicly confirmed any weight-loss regimen, medication use or health issues. No official statements from her representatives have addressed the speculation.

Wilde appeared at the 2026 Met Gala on May 4 in a black Thom Browne gown styled by Karla Welch. Photos from the event showed her in a form-fitting off-the-shoulder design with an exposed bustle detail on the back.

Public discussion intensified after podcaster Megyn Kelly commented on the festival video. Kelly described Wilde as looking “truly unwell” and expressed concern over her appearance, though she noted no confirmation of Ozempic or similar drug use.

Social media reactions included a mix of worry, criticism and defense. Some users praised her look, while others called for body positivity and cautioned against speculation. Celebrity injector accounts and wellness commentators also weighed in, discussing possible cosmetic procedures or rapid fat loss effects.

Advertisement

Wilde has maintained an active schedule promoting “The Invite” and attending industry events. She previously starred in and directed films including “Booksmart” and “Don’t Worry Darling.” Her career spans acting roles in “House,” “Tron: Legacy” and “The Lazarus Effect.”

The conversation reflects broader Hollywood trends around weight, appearance and public scrutiny. Similar speculation has surrounded other celebrities in recent years regarding GLP-1 medications like Ozempic.

Wilde has not shared details about her fitness routine, diet or any intentional weight changes. She has historically maintained a relatively private personal life while navigating high-profile relationships and professional demands.

Fans and commentators continue to share before-and-after comparisons from 2023 to 2026. Some posts highlight perceived changes in facial volume, including temples and cheeks, often linked in discussions to buccal fat removal trends or rapid weight loss.

Advertisement

The actress attended the Fashion Trust U.S. 2026 Awards in Los Angeles earlier in the year wearing a design by Ashlyn. She has continued red-carpet appearances without further direct commentary on the viral video.

Medical experts not involved in her care have not commented publicly. Rapid weight loss can sometimes result in facial volume loss, skin changes or other visible effects, though individual results vary widely.

Wilde’s team has not issued statements confirming or denying any medical conditions. The discussion remains driven by public observation and social media commentary.

The San Francisco International Film Festival appearance marked one of several promotional events for “The Invite.” The project has generated attention beyond Wilde’s personal appearance.

Advertisement

As of mid-May 2026, no new public appearances have reignited the same level of speculation. Wilde continues her work as both actress and director amid ongoing industry commitments.

The incident highlights the intense scrutiny faced by public figures regarding physical changes. Online platforms amplify both supportive and critical voices in real time.

Wilde has previously addressed body image and wellness topics indirectly through her projects and interviews, though she has not spoken specifically about recent changes. Her focus remains on professional endeavors in film.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

What the ‘Dean of Valuation’ Thinks SpaceX Is Really Worth

Published

on

Spencer Jakab hedcut

Aswath Damodaran is skeptical of the outlook for SpaceX’s artificial-intelligence unit. The professor of corporate finance at NYU’s Stern School of Business estimates the equity value at SpaceX is around $1.3 trillion.

Continue Reading

Business

On Holdings: Sprinting For Growth (NYSE:ONON)

Published

on

On Holdings: Sprinting For Growth (NYSE:ONON)

This article was written by

– Banaging a consistent, low-risk value compounding portfolio—no gambling, no hype, just fundamentals. I aim to generate ~12% average annual returns over 3-5 year stretches with minimal downside risk, prioritizing capital preservation and stable value compounding over short-term momentum. – With over a decade of professional experience in equity research, I specialize in analyzing cash-generative businesses, special situations, and corporate restructurings across developed markets. My investment strategy emphasizes risk assessment over speculative growth, aligning with contrarian and value-driven principles. – Influenced by legendary investors like Warren Buffett and Howard Marks, I rely on deep fundamental analysis, macroeconomic context, and rigorous valuation discipline. I hold a First-Class Honors degree in Economics from the University of London and am passionate about translating complex financial insights into actionable long-term investment ideas.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

SpaceX’s Army of Individual Investors Showed Up

Published

on

Spencer Jakab hedcut

Individual investors showed up for Elon Musk in the SpaceX IPO. Individuals put in orders for around $100 billion in the offering, according to people familiar with the matter.

While they received a fraction of that, the strong demand highlighted the sway individual investors now hold in U.S. public markets.

The majority of shares in the IPO still went to institutional investors, but around 20% were directed to individuals, or around $15 billion worth. While many banks focused on selling IPO shares to their institutional investor clients, Bank of America led underwriter efforts to sell shares to individuals in the U.S.

Continue Reading

Business

Switzerland votes on proposal to cap population at 10 million

Published

on

Switzerland votes on proposal to cap population at 10 million


Switzerland votes on proposal to cap population at 10 million

Continue Reading

Business

Momentum and Small-Caps Lead Market Amid Big IPO

Published

on

Stocks Little Changed After Fed Decision

It’s fitting that the largest IPO ever debuted on a day that Wall Street was back chasing momentum stocks.

The S&P 500 was up 0.5%. The Nasdaq was up 0.4%. The Dow was up 384 points, or 0.8%. SpaceX stock was up 27% to $170.88 in its debut so far, which puts it right around TSMC among the top seven companies by market cap.

The top exchanged-traded funds focused on stocks with particular characteristics, or factors, were mostly momentum, risk, and growth focused on Friday.

Continue Reading

Business

Adobe CFO Heads to a Chip Firm. It’s All You Need to Know About Software’s Downfall.

Published

on

Adobe CFO Heads to a Chip Firm. It’s All You Need to Know About Software’s Downfall.

Adobe CFO Heads to a Chip Firm. It’s All You Need to Know About Software’s Downfall.

Continue Reading

Business

Microsoft Stock Is Having a Rough Week. It’s the Latest AI Play Under Pressure.

Published

on

Microsoft Stock Is Having a Rough Week. It’s the Latest AI Play Under Pressure.

Microsoft Stock Is Having a Rough Week. It’s the Latest AI Play Under Pressure.

Continue Reading

Business

Coming to Grips With a Trillion-Dollar Sum

Published

on

Spencer Jakab hedcut

Not long ago, the word trillionaire only appeared in The Wall Street Journal as hyperbole. It was an obviously exaggerated way of describing an inconceivable fortune—like calling someone a bazillionaire. But now with SpaceX going public, we are today using it for Elon Musk.

Continue Reading

Business

Hopes for Iran Peace Deal Sparked Quick Rally in Luxury Stocks. Is It Time to Buy?

Published

on

Hopes for Iran Peace Deal Sparked Quick Rally in Luxury Stocks. Is It Time to Buy?

Hopes for Iran Peace Deal Sparked Quick Rally in Luxury Stocks. Is It Time to Buy?

Continue Reading

Business

FDA issues highest-risk recall for Alfredo sauce sold in 41 states

Published

on

FDA issues highest-risk recall for Alfredo sauce sold in 41 states

The Food and Drug Administration (FDA) has classified a recall of more than 900 cases of Alfredo sauce at its highest risk level after a supplier recalled a dry milk powder ingredient used in the product due to potential salmonella contamination.

The FDA designated the recall as a Class I event, its most serious classification, meaning there is a reasonable probability that use of or exposure to the product could cause serious adverse health consequences or death.

Advertisement

The recall affects 913 cases of Alfredo sauce packaged in 3-pound, 7-ounce sealed poly bags and 12 bags per case, according to an FDA enforcement report.

FORD RECALLS MORE THAN 255,000 FOCUS VEHICLES OVER ENGINE STALL RISK

Fettuccine Alfredo being prepared in a pan

Fettuccine Alfredo is prepared in a kitchen. The FDA classified a recall of more than 900 cases of Alfredo sauce as a Class I event due to potential salmonella contamination. (Getty Images / Getty Images)

According to the FDA, The Coffee Connexion Co., Inc., which is based in Lebanon, Tennessee, voluntarily initiated the recall on May 6, after a supplier recalled a dry milk powder ingredient used in the product due to potential salmonella contamination. The recall remains ongoing.

A representative for The Coffee Connexion Co. did not immediately respond to FOX Business’ request for comment.

Advertisement

The affected product carries UPC 0039954921963 and includes batches 046188 through 046193 with a best-by date of Jan. 12, 2028; batches 047290 through 047296 with a best-by date of Feb. 16, 2028; batches 048029 through 048034 with a best-by date of March 9, 2028; and batches 049089 through 049094 with a best-by date of April 20, 2028.

MORE THAN 17K COFFEE MAKERS RECALLED AFTER DOZENS OF REPORTED BURN INJURIES

Fettuccini Alfredo on a plate

A serving of fettuccine Alfredo is served. The recalled product was distributed in more than 40 states, according to the FDA. (iStock / iStock)

According to the FDA, the product was distributed in Alabama, Arkansas, Arizona, California, Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, Nebraska, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin and Wyoming.

Salmonella can cause serious and sometimes fatal infections in young children, older adults and people with weakened immune systems. Healthy people infected with salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain, according to the FDA.

Advertisement
Store shelves at Walmart

According to the FDA, the product was distributed in 41 states. (Brian Kaiser/Bloomberg via Getty Images, File / Getty Images)

The FDA’s enforcement report states that no press release was issued for the recall and does not indicate whether any illnesses have been reported.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

The recall was assigned FDA recall number H-0909-2026 and received its Class I classification on June 4.

Advertisement
Continue Reading

Trending

Copyright © 2025